Biotech stocks have tumbled in recent months and years. For example, the SPDR S&P Biotech ETF (NYSE:XBI) has sunk 40% so far this year. As a result, there are many oversold biotech stocks for investors to buy.
But in the next six months, two main factors should push the sector much higher.
The post 3 Oversold Biotech Stocks to Buy Now appeared first on InvestorPlace.